Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Tue, Apr 22, 2025 02:31 AM All times are UTC

Follow Series

©Econometrics LLC . All Rights Reserved.

Anthony Scott1

Professor of Vaccine Epidemiology, Director HPRU in Immunisation, London School of Hygiene & Tropical Medicine
My areas of interest are infectious disease epidemiology and vaccine research. I completed an MRC(UK)-funded PhD in 2016 that included studies to assess whether human papillomavirus (HPV) infection increased HIV acquisition in East African women, to evaluate HPV vaccine introduction in Tanzania and to collate 'lessons learnt' during HPV vaccine introduction in 46 low and middle-income countries. Whilst based at the Mwanza Intervention Trials Unit in Tanzania for 2014 and 2015, I also aided the initial set-up of the EBOVAC1 Ebola vaccine Phase 1 trial. As a post-doc, I worked as the London-based academic coordinator of the EBOVAC1 projects including two large phase 2b vaccine trials in Sierra Leone and 2 nested observational studies.

Since July 2018 I have been based at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, setting up a trial to assess whether lower doses of the two currently available pneumococcal conjugate vaccines protect Kenyan infants as well as the full dose schedules. We will compare the immune response and carriage of the pneumococcus in the nose (a surrogate marker for disease) after vaccination with a full, 40% or 20% dose schedule. The results could be used to enable countries unable to afford the full cost of the vaccine, to continue delivering it in the childhood immunisation programme in the absence of Gavi support.

Will the US trade war push up the price of medicines in Australia? Will there be drug shortages?

Mar 22, 2025 05:36 am UTC| Insights & Views Business

Talks of a trade dispute between the United States and Australia over the cost of medicines have no doubt left many Australians scratching their heads. With all this talk of attacks on the Pharmaceutical Benefits Scheme...

Economy

Philippines Posts $2 Billion BOP Deficit in March Amid Economic Headwinds

The Philippines recorded a $2 billion balance of payments (BOP) deficit in March 2025, reversing a $3.1 billion surplus in February, according to the Bangko Sentral ng Pilipinas (BSP). This shift pushed the countrys...

Indonesia’s March Exports Beat Expectations with $23.25B Surge

Indonesias exports rose by 3.16% year-on-year in March 2025, reaching $23.25 billion, according to data released by Statistics Indonesia on Monday. This performance exceeded market expectations, which had forecast a 3.40%...

EU May Soften Methane Rules to Boost U.S. LNG Imports Amid Trade Tensions

The European Union is considering easing the application of its methane emissions regulations to help U.S. liquefied natural gas (LNG) exports comply with its new climate rules, sources told Reuters. The move comes as the...

Japan Core Inflation Accelerates in March, Complicating BoJ Rate Outlook

Japans core consumer inflation rose in March, fueled by persistent food price hikes, adding complexity to the Bank of Japans (BoJ) rate trajectory amid ongoing U.S. tariff tensions. According to official data released...

Dollar Plunges to Three-Year Low Amid Fed Shake-Up Fears and Trade Uncertainty

The U.S. dollar fell sharply on Monday, hitting multi-year lows against major currencies as fears mounted over the independence of the Federal Reserve and escalating trade tensions. Investor sentiment weakened after...

Politics

China Imposes Sanctions on U.S. Officials Over Hong Kong Dispute

BEIJING China has announced sanctions targeting several U.S. lawmakers, government officials, and heads of non-governmental organizations in retaliation for what it described as egregious behavior concerning Hong Kong....

JD Vance Visits India Amid U.S.-India Trade Talks and Growing Diplomatic Ties

U.S. Vice President JD Vance began a four-day visit to India on Monday, aiming to strengthen diplomatic and trade relations as both countries work toward a potential trade deal. Vance is scheduled to meet Prime Minister...

Trump Threatens to Cut $1B in Health Research Funds to Harvard Amid Campus Protest Tensions

U.S. President Donald Trump is escalating his administrations conflict with elite universities, threatening to cut an additional $1 billion in federal health research funding to Harvard University, according to the Wall...

China Warns Against Trade Deals That Undermine Its Interests

China has issued a strong warning against any economic or trade agreements made at its expense, responding to reports that the U.S. is pressuring other nations to curb trade with China in exchange for tariff exemptions. In...

Pentagon Leak Probe Sparks Backlash After Advisor Ouster

Dan Caldwell, a former top adviser to U.S. Defense Secretary Pete Hegseth, has spoken out following his sudden removal from the Pentagon amid a controversial leak investigation. In a joint statement with fellow ousted...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Nintendo Faces Tariff Hurdles Ahead of Switch 2 Launch

Nintendo is preparing to launch the highly anticipated Switch 2 on June 5, marking eight years since the original Switch debuted. The console, which sold over 150 million units globally, became a pandemic-era favorite....

Apple iPhone Sales Drop 9% in China as Xiaomi Surges 40%

Apples iPhone shipments in China dropped 9% year-over-year in Q1 2025, making it the only major smartphone brand to report a decline, according to IDC. The U.S. tech giant shipped 9.8 million iPhones during the quarter,...

Nvidia Faces $5.5B Hit as U.S. Restricts H20 AI Chip Exports to China

Nvidia (NASDAQ:NVDA) announced it will incur $5.5 billion in charges after the U.S. government indefinitely restricted exports of its H20 AI chip to China, a critical market for its data center products. The H20 chip,...

Intel Restructures Leadership Under New CEO to Boost AI and Engineering Focus

Intels new CEO, Lip-Bu Tan, has initiated a major leadership shakeup aimed at streamlining operations and reviving the chipmakers competitive edge. In a recent internal memo obtained by Reuters, Tan announced a flatter...

TSMC Q1 Profit Surges 60% on Booming AI Chip Demand

Taiwan Semiconductor Manufacturing Co (TSMC), the worlds largest contract chipmaker, reported a 60% year-over-year surge in first-quarter net profit, driven by skyrocketing demand for chips powering artificial intelligence...